Drug Shortage Report for PMS-PRAVASTATIN

Last updated on 2020-06-10 History
Report ID 4271
Drug Identification Number 02247656
Brand name PMS-PRAVASTATIN
Common or Proper name PRAVASTATIN
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) PRAVASTATIN SODIUM
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-23
Estimated end date Unknown
Actual end date 2020-06-09
Shortage status Resolved
Updated date 2020-06-10
Company comments Format discontinued
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-06-10 French Compare
v7 2020-06-10 English Compare
v6 2017-06-16 French Compare
v5 2017-06-16 English Compare
v4 2017-04-11 French Compare
v3 2017-04-11 English Compare
v2 2017-03-24 French Compare
v1 2017-03-24 English Compare

Showing 1 to 8 of 8